Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Plos One|August 22, 2008
Regenerating articular tissue by converging technologiesLorenzo Moroni, Doreen Hamann, Luca Paoluzzi, et al.
Anticancer Research|June 25, 2003
Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: a phase I studyEnrico Cortesi, Federico Grifalchi, Sara Ramponi, et al.
Cancer Medicine|May 13, 2016
BET and BRAF inhibitors act synergistically against BRAF-mutant melanomaLuca Paoluzzi, Douglas Hanniford, Elena Sokolova, et al.
American Journal of Clinical Oncology|December 15, 2004
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experienceUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
American Journal of Clinical Oncology|October 21, 2020
Modern Management of High-risk Soft Tissue Sarcoma With Neoadjuvant Chemoradiation: A Single-center ExperienceDavid J Byun, Leah M Katz, Julie Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignanciesEnrica Marchi, Luca Paoluzzi, Luigi Scotto, et al.
Anticancer Research|June 25, 2003
Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancerAndrea Mancuso, Rosa Giuliani, Caterina Accettura, et al.
Leukemia & Lymphoma|April 11, 2015
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphomaDanielle Bongero, Luca Paoluzzi, Enrica Marchi, et al.
Journal of Clinical Pharmacology|August 3, 2004
Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38Luca Paoluzzi, Arun S Singh, Douglas K Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Development and characterization of a novel CD19CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomasLuigi Scotto, Marianna Kruithof-de Julio, Luca Paoluzzi, et al.
Pageof 3